Benjamin R. Cowen
Director/Board Member chez INCON CO.,LTD.
Profil
Currently, Benjamin R.
Cowen holds the position of President & Chief Executive Officer of ImmunoMet Therapeutics, Inc. Dr. Cowen is also on the board of INCON Co., Ltd.
and Atrin Pharmaceuticals LLC.
Dr. Cowen previously held the position of Vice President-Corporate Development of Milestone Pharmaceuticals, Inc.
Benjamin R.
Cowen received a doctorate from the University of Illinois and an MBA from Carnegie Mellon University.
Postes actifs de Benjamin R. Cowen
Sociétés | Poste | Début |
---|---|---|
INCON CO.,LTD. | Director/Board Member | - |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Director/Board Member | 01/01/2012 |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Chief Executive Officer | 01/11/2017 |
Anciens postes connus de Benjamin R. Cowen
Sociétés | Poste | Fin |
---|---|---|
MILESTONE PHARMACEUTICALS INC. | Corporate Officer/Principal | - |
Formation de Benjamin R. Cowen
Carnegie Mellon University | Masters Business Admin |
University of Illinois | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
MILESTONE PHARMACEUTICALS INC. | Health Technology |
INCON CO.,LTD. | Consumer Durables |
Entreprise privées | 2 |
---|---|
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Health Technology |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Health Technology |